Becton Dickinson & Co (BDX): who owns it and who trades it
As of Nov 16, 2026, BDX insiders reported 22 open-market sales worth $3.4M and no purchases in the last 12 months, with 82% of the sale value made under pre-set 10b5-1 plans. The largest seller was Thomas E Polen Jr (CEO), with $1.8M. 9 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Becton Dickinson
From the latest filingsOverall: more selling than buying. Insiders and Congress mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns BDX
1,431 funds and institutions reported BDX shares worth $43.7B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is First Eagle Investment Management, LLC with 10.1%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| First Eagle Investment Management, LLC | 27.63M | 10.14% | $4.2B | +132% |
| BlackRock, Inc. | 24.59M | 9.03% | $3.7B | -6% |
| Vanguard Capital Management LLC | 17.99M | 6.60% | $2.7B | -3% |
| State Street Corp | 15.00M | 5.51% | $2.3B | +9% |
| Vanguard Portfolio Management LLC | 14.97M | 5.50% | $2.3B | -2% |
| Invesco Ltd. | 8.90M | 3.27% | $1.3B | -13% |
| Massachusetts Financial Services Co | 8.65M | 3.18% | $2.5B | -5% |
| Geode Capital Management, LLC | 8.14M | 2.99% | $1.2B | +15% |
| Franklin Resources Inc | 7.01M | 2.57% | $1.1B | +31% |
| Wellington Management Group LLP | 6.36M | 2.33% | $962M | -4% |
| Greenhaven Associates Inc | 5.68M | 2.09% | $860M | – |
| Norges Bank | 4.17M | 1.53% | $631M | – |
| T. Rowe Price Associates | 3.91M | 1.43% | $591M | -12% |
| T. Rowe Price Investment Management, Inc. | 3.72M | 1.37% | $563M | -62% |
| American Century Companies Inc | 3.68M | 1.35% | $556M | +8% |
| Charles Schwab Investment Management Inc | 3.40M | 1.25% | $515M | +2% |
| Sixth Street Partners Management Company, L.P. | 3.40M | 1.25% | $515M | – |
| Morgan Stanley | 3.32M | 1.22% | $502M | -17% |
| Clearbridge Investments, LLC | 3.23M | 1.19% | $489M | -22% |
| Bank of America Corp | 3.14M | 1.15% | $475M | +18% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, BDX insiders reported $0 of open-market purchases and $3.4M of sales. 82% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nov 5, 2026 | Thomas E Polen Jr | CEO | Sale plan | 2,993 | $210.00 | $629K | Form 4 |
| Oct 26, 2026 | Michael Feld | Vice president | Sale plan | 76 | $198.13 | $15.1K | Form 4 |
| Sep 28, 2026 | Michael Feld | Vice president | Sale plan | 76 | $183.70 | $14K | Form 4 |
| Aug 26, 2026 | Michael Feld | Vice president | Sale plan | 165 | $188.49 | $31.1K | Form 4 |
| Aug 13, 2026 | Thomas E Polen Jr | CEO | Sale plan | 4,152 | $185.00 | $768K | Form 4 |
| Aug 11, 2026 | Roland Goette | Vice president | Sale | 2,438 | $180.84 | $441K | Form 4 |
| Jul 27, 2026 | Michael Feld | Vice president | Sale plan | 75 | $157.13 | $11.8K | Form 4 |
| Jun 26, 2026 | Michael Feld | Vice president | Sale plan | 75 | $152.80 | $11.5K | Form 4 |
| Jun 24, 2026 | Michael David Garrison | Vice president | Sale plan | 1,100 | $145.66 | $160K | Form 4 |
| Jun 10, 2026 | Michael David Garrison | Vice president | Sale plan | 1,100 | $151.48 | $167K | Form 4 |
| Jun 1, 2026 | Thomas E Polen Jr | CEO | Sale plan | 2,764 | $146.35 | $405K | Form 4 |
| May 26, 2026 | Michael Feld | Vice president | Sale plan | 75 | $147.35 | $11.1K | Form 4 |
| Apr 27, 2026 | Michael Feld | Vice president | Sale plan | 74 | $151.94 | $11.2K | Form 4 |
| Mar 26, 2026 | Michael Feld | Vice president | Sale plan | 75 | $156.83 | $11.8K | Form 4 |
| Feb 26, 2026 | Michael Feld | Vice president | Sale plan | 75 | $181.84 | $13.6K | Form 4 |
| Feb 18, 2026 | Bertram L Scott | Director | Sale | 953 | $182.61 | $174K | Form 4 |
| Jan 26, 2026 | Michael Feld | Vice president | Sale plan | 75 | $202.73 | $15.2K | Form 4 |
| Jan 15, 2026 | Michael David Garrison | Vice president | Sale plan | 1,010 | $206.54 | $209K | Form 4 |
| Jan 15, 2026 | Michael David Garrison | Vice president | Sale plan | 600 | $209.00 | $125K | Form 4 |
| Dec 26, 2025 | Michael Feld | Vice president | Sale plan | 74 | $196.08 | $14.5K | Form 4 |
| Dec 17, 2025 | Michael David Garrison | Vice president | Sale plan | 629 | $196.03 | $123K | Form 4 |
| Dec 1, 2025 | Michael Feld | Vice president | Sale plan | 75 | $193.36 | $14.5K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Thomas E Polen Jr | Chairman, CEO and President, Director | – | $1.8M | Nov 5, 2026 |
| Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | – | $784K | Jun 24, 2026 |
| Roland Goette | EVP and President, EMEA | – | $441K | Aug 11, 2026 |
| Michael Feld | EVP, CRO & Pres. Life Sciences | – | $175K | Oct 26, 2026 |
| Bertram L Scott | Director | – | $174K | Feb 18, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
BDX short interest
Low short interest. 3.0% of BDX shares are sold short: about 1 share in 34. Over the last 12 reports the number of shares short went down 4%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 8.11M BDX shares were sold short, 3.0% of the shares outstanding, down 9.0% from the report before. At the average daily volume of 1.56M shares, buying them all back would take about 5.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 8.11M | 2.98% | -9% | 1.56M | 5.2 |
| Oct 15, 2026 | 8.91M | 3.27% | -9% | 1.62M | 5.5 |
| Sep 30, 2026 | 9.78M | 3.59% | -14% | 2.00M | 4.9 |
| Sep 15, 2026 | 11.32M | 4.15% | +6% | 1.57M | 7.2 |
| Aug 31, 2026 | 10.67M | 3.92% | +14% | 1.74M | 6.1 |
| Aug 14, 2026 | 9.37M | 3.44% | -6% | 1.95M | 4.8 |
| Jul 31, 2026 | 10.02M | 3.68% | -4% | 1.75M | 5.7 |
| Jul 15, 2026 | 10.38M | 3.81% | -8% | 1.78M | 5.8 |
| Jun 30, 2026 | 11.24M | 4.13% | +54% | 3.87M | 2.9 |
| Jun 15, 2026 | 7.28M | 2.64% | +1% | 2.02M | 3.6 |
| May 29, 2026 | 7.20M | 2.61% | -14% | 2.98M | 2.4 |
| May 15, 2026 | 8.41M | 3.05% | +32% | 3.70M | 2.3 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Members of Congress who traded BDX
Since Nov 17, 2024, 6 members of Congress reported 4 purchases and 5 sales of BDX. The latest was a sale by Thomas H. Kean, Jr. on May 21, 2026, reported Jun 18, 2026.
Purchases 4Sales 5
Reported trades
| Trade date | Member | Type | Amount | Owner | Reported | Source |
|---|---|---|---|---|---|---|
| May 21, 2026 | Thomas H. Kean, Jr. (R-NJ) | Sale | $1K–$15K | Self | Jun 18, 2026 | Report |
| Mar 27, 2026 | Alan Armstrong (R-OK) | Purchase | $1K–$15K | Self | Jul 21, 2026 | Report |
| Mar 17, 2026 | Kevin Hern (R-OK) | Sale | $15K–$50K | Joint | Apr 3, 2026 | Report |
| Jun 24, 2025 | Lisa C. McClain (R-MI) | Sale | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| Jun 17, 2025 | Lisa C. McClain (R-MI) | Purchase | $1K–$15K | Spouse | Aug 13, 2025 | Report |
| May 15, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Purchase | $1K–$15K | Self | Jun 9, 2025 | Report |
| May 13, 2025 | Thomas H. Kean, Jr. (R-NJ) | Purchase | $1K–$15K | Self | Jun 17, 2025 | Report |
| Apr 8, 2025 | Robert P. Bresnahan, Jr. (R-PA) | Sale | $1K–$15K | Self | Apr 28, 2025 | Report |
| Mar 5, 2025 | Jefferson Shreve (R-IN) | Sale | $15K–$50K | Self | Apr 11, 2025 | Report |
Source: Periodic Transaction Reports filed with the Clerk of the House and the Secretary of the Senate under the STOCK Act. Members report each trade within 45 days, as a dollar range, not an exact amount. Trades by a spouse or dependent child are included and marked. Paper filings (scanned images) are not included, and Senate reports are shown for current senators only. Links to Senate reports open the Senate’s own site, which shows its terms first and can only be reached from the United States. How these reports work
Becton Dickinson company events
Becton Dickinson filed 20 reports on Form 8-K in the last 12 months, 7 of them about an important change (leadership). The latest was on Nov 5, 2026.
- Nov 5, 2026ResultsReleased financial results. Filing
- Aug 6, 2026ResultsReleased financial results. Filing
- Jul 22, 2026LeadershipMichael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments of Becton, Dickinson and Company, informed BD of his intention to retire. Filing
- May 29, 2026AnnouncementShared information with investors. Filing
- May 20, 2026AgreementBecton Dickinson Euro Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg and an indirect, wholly-owned subsidiary of Becton, Dickinson and Company, issued €600,000,000 of its 3.855% Notes due 2033 in… Filing
- May 12, 2026AnnouncementBecton, Dickinson and Company, together with its indirect, wholly-owned subsidiary, Becton Dickinson Euro Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg, entered into an underwriting agreement… Filing
- May 7, 2026LeadershipAmended an earlier report. Of Becton, Dickinson and Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 15, 2025. Filing
- May 7, 2026ResultsReleased financial results. Filing
- Apr 29, 2026RulesChanged its bylaws or articles. Filing
- Apr 9, 2026LeadershipRichard E. Byrd, Executive Vice President and President of the Interventional segment of Becton, Dickinson and Company, informed BD of his intention to retire. Filing
- Apr 2, 2026ResultsReleased financial results. Filing
- Feb 25, 2026AnnouncementBecton, Dickinson and Company announced the early tender results for its previously announced tender offers to purchase for cash, subject to prioritized acceptance levels, series-specific aggregate principal amount caps, if any (each, an “Offer SubCap”), and proration if applicable, up to $2… Filing
- Feb 10, 2026AnnouncementBecton, Dickinson and Company announced that it commenced a series of tender offers to purchase for cash, subject to prioritized acceptance levels, series-specific aggregate principal amount caps, if any, and proration if applicable, up to $1.6 billion aggregate purchase price (excluding the… Filing
- Feb 9, 2026LeadershipIn connection with the completion of the Transactions, and effective as of the Closing, Claire M. Fraser, Ph.D., resigned as a director of the Company and was appointed to the Waters board of directors. Filing
- Feb 9, 2026ResultsReleased financial results. Filing
- Feb 5, 2026SharesSold new shares outside a public offering. Filing
- Feb 5, 2026AnnouncementShared information with investors. Filing
- Jan 30, 2026LeadershipThe Board of Directors of Becton, Dickinson and Company approved and adopted the BD Executive Severance Plan, effective January 27, 2026. Filing
- Dec 1, 2025LeadershipAmended an earlier report. DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS. In connection with their appointments to the Board, effective December 1, 2025, Mr. Huffines and Ms. Wright will each receive restricted stock units valued at $33,575, representing a prorated… Filing
- Nov 17, 2025LeadershipRobert L. Huffines and Jacqueline Wright were elected to the Board of Directors of Becton, Dickinson and Company, effective December 1, 2025. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Becton Dickinson financials
Famous investors that hold BDX
9 of the 50 well-known investors we track reported holding BDX in their latest 13F filing. The largest position is Edgar Wachenheim's, worth $1.1B.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Edgar Wachenheim · Greenhaven Associates | Q3 2026 | 5.90M | $1.1B | 13.3% | +4% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 2.77M | $495M | 0.3% | +2227% |
| Bill Nygren · Harris Associates (Oakmark) | Q3 2026 | 2.23M | $399M | 0.5% | -5% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 330,668 | $59.2M | 0.1% | New |
| Israel Englander · Millennium Management | Q3 2026 | 65,568 | $11.7M | 0.0% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 59,283 | $10.6M | 0.0% | New |
| Ray Dalio · Bridgewater Associates | Q3 2026 | 8,941 | $1.6M | 0.0% | -5% |
| Jeremy Grantham · GMO | Q3 2026 | 8,069 | $1.4M | 0.0% | -36% |
| Lee Ainslie · Maverick Capital | Q3 2026 | 1,255 | $225K | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Becton Dickinson & Co (BDX) stock
Who owns the most BDX stock?
The largest reported owner of Becton Dickinson & Co (BDX) is First Eagle Investment Management, LLC, with 10.1% of the company. In total, 1,431 funds and institutions reported holding BDX at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are BDX insiders buying or selling?
In the last 12 months, BDX insiders reported no open-market purchases and 22 sales worth $3.4M. The latest trade was on Nov 5, 2026. See every trade.
What is the short interest in BDX?
As of Oct 30, 2026, 8.11M BDX shares were sold short, 3.0% of the shares outstanding, down 9.0% from the report before. At the average daily volume of 1.56M shares, buying them all back would take about 5.2 trading days (days to cover). See the history.
Have members of Congress traded BDX?
Yes. 6 members of Congress reported 4 purchases and 5 sales of BDX since Nov 17, 2024. The latest was reported on Jul 21, 2026. See the trades.
Which famous investors hold BDX?
9 of the 50 well-known investors we track reported BDX in their latest 13F filing, including Edgar Wachenheim, Ken Griffin, Bill Nygren. The largest position is worth $1.1B. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.